AIM ImmunoTech Inc. AIM 26.57
Health Care · NYSE · Data as of 2026-09-30
AIM ImmunoTech Inc. (AIM) has delivered -6.0% annualized revenue growth, n/a earnings growth, and n/a dividend growth over 10 years of data. Ranked #1931 of 1968 stocks overall and #251 of 260 in the Health Care sector by Steady Score.
Industry
Biological Products
Steady Score
26.57
Overall Rank
#1931 / 1968
Sector Rank
#251 / 260
Revenue CAGR
-6.0%
Earnings CAGR
-
Dividend CAGR
-
?
E/R CAGR Ratio
-
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio